Monopar Therapeutics (MNPR) had the highest return between December 17, 2019 and December 23, 2019 by a small-cap US stock or small-cap US stock, returning 160.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Monopar Therapeutics (MNPR) | 12/17/2019 - 12/23/2019 | 160.36% |
Neurogene (NGNE) | 12/17/2019 - 12/23/2019 | 56.27% |
Gyre Therapeutics (GYRE) | 12/17/2019 - 12/23/2019 | 46.24% |
Tetra Technologies (TTI) | 12/17/2019 - 12/23/2019 | 43.66% |
Akso Health Group ADR (AHG) | 12/17/2019 - 12/23/2019 | 41.52% |
Helius Medical Technologies Inc Class A (HSDT) | 12/17/2019 - 12/23/2019 | 40.82% |
Fulcrum Therapeutics (FULC) | 12/17/2019 - 12/23/2019 | 33.33% |
Prothena (PRTA) | 12/17/2019 - 12/23/2019 | 32.68% |
FuelCell Energy (FCEL) | 12/17/2019 - 12/23/2019 | 29.23% |
Phathom Pharmaceuticals (PHAT) | 12/17/2019 - 12/23/2019 | 28.49% |
10X Genomics (TXG) | 12/17/2019 - 12/23/2019 | 27.55% |
LifeMD (LFMD) | 12/17/2019 - 12/23/2019 | 27.27% |
RAPT Therapeutics (RAPT) | 12/17/2019 - 12/23/2019 | 26.19% |
Lightbridge (LTBR) | 12/17/2019 - 12/23/2019 | 26.1% |
Lsb Industries (LXU) | 12/17/2019 - 12/23/2019 | 25.13% |
Cresud SACIF y A (CRESY) | 12/17/2019 - 12/23/2019 | 23.45% |
CytomX Therapeutics (CTMX) | 12/17/2019 - 12/23/2019 | 22.9% |
Arbutus Biopharma (ABUS) | 12/17/2019 - 12/23/2019 | 22.77% |
DiaMedica Therapeutics (DMAC) | 12/17/2019 - 12/23/2019 | 22.42% |
Clearpoint Neuro (CLPT) | 12/17/2019 - 12/23/2019 | 22.19% |
Grupo Supervielle (SUPV) | 12/17/2019 - 12/23/2019 | 20.91% |
Dianthus Therapeutics (DNTH) | 12/17/2019 - 12/23/2019 | 20.73% |
Concrete Pumping Holdings Class A (BBCP) | 12/17/2019 - 12/23/2019 | 20.48% |
Cellectis (CLLS) | 12/17/2019 - 12/23/2019 | 19.66% |
Savara (SVRA) | 12/17/2019 - 12/23/2019 | 19.61% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
